About PlenOptika
PlenOptika is a Healthcare company based in Cambridge (United States) founded in 2014 by Nicholas Durr, Daryl Lim, Eduardo Lage, and Shivang Dave. Developer of a medical devices for measuring refractive errors. PlenOptika has raised $50.38 thousand across 3 funding rounds from investors including HHS. Its chief executive, as recorded, is Shivang Dave. PlenOptika offers products and services including QuickSee Free and QuickSee Free Pro. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Imaging. Its competitors include ArcScan, EyeNetra and Smart Vision Labs; 3 of its 3 listed competitors have raised funding.
Company details
PlenOptika is a developer of medical devices for measuring refractive errors. The objective of the device is based on dynamic aberrometry and smart Rx algorithms. It helps to precisely determine low-order refractive errors. The device is binocular with an open view to help reduce instrument induced myopia.
- Headquarters Cambridge, United States
- Founders Nicholas Durr, Daryl Lim, Eduardo Lage, Shivang Dave
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website plenoptika.com
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$50.38K (USD)
in 3 rounds
- Latest Funding Round$300.14K (USD), Grant
Sep 2017
- Investors
Products & Services of PlenOptika
PlenOptika offers a comprehensive portfolio of products and services, including QuickSee Free and QuickSee Free Pro.
Device for quick and accurate eye refraction measurements in various settings.
Advanced tool for refraction and corneal curvature assessment in clinical use.
Funding Insights of PlenOptika
PlenOptika has successfully raised a total of $50.38K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $300.14 thousand completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50,383
- Total Rounds 3
- Last Round Grant — $300,139
- First Round $2.65M
(Sep 2015)
- Investors Count 1
All 3 funding rounds of PlenOptika with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in PlenOptika
PlenOptika has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for PlenOptika
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PlenOptika
27 people are tracked at PlenOptika (8 in leadership, 15 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Nicholas Durr | Co-Founder | Leadership |
Daryl Lim | Co-Founder & COO | Leadership |
Eduardo Lage | Co-Founder & CTO | Leadership |
Shivang Dave | Co-Founder & CEO | Leadership |
Carlos Santiago Hernández | Director of Engineering | Leadership |
Eric Norman | Director of Communications | Leadership |
Oscar Lazaro | VP, Strategic Growth Initiatives | Leadership |
John Strobel | VP, Sales | Leadership |
Dave Sattler | Advisor | Board & advisors |
Huy Tran | Advisor | Board & advisors |
Gary Y. Chu | Advisor | Board & advisors |
Thomas A Wong | Advisor | Board & advisors |
Will Febbo | Board Member | Board & advisors |
Nick Durr | Co-Founder | Board & advisors |
Nikita Imennov | Board Member | Board & advisors |
Edward Chung | Advisor | Board & advisors |
Marta Gaia-Zanchi | Board Member | Board & advisors |
Susana Marcos | Advisor | Board & advisors |
Ahhyun Stephanie Nam | Advisor | Board & advisors |
Darius Moshfeghi | Advisor | Board & advisors |
7 more people are available in the full profile.
Complete people profiles for PlenOptika
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PlenOptika
3 dated milestones of PlenOptika across 3 years, from founding to its latest funding, stage changes and deals.
- Founded PlenOptika is founded.
- Funding First funding round of $2.7M.
- Funding Latest funding round, Grant, of $300K.
Competitors of PlenOptika
PlenOptika has 3 listed competitors in our database, 3 of them funded. They include ArcScan, EyeNetra and Smart Vision Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| arcscan.com | 2007 | Golden, United States | $15.21M | 18 | Ultrasound device for micron-resolution anterior chamber imaging is provided. | |
| eyenetra.com | 2011 | Somerville, United States | $7M | 3 | Refractive errors are measured using smartphone camera attachments. | |
| smartvisionlabs.com | 2013 | New York, United States | $6.1M | Refractive errors are tested via smartphone attachment by healthcare professionals. |
Detailed competitors of PlenOptika
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PlenOptika
The website of PlenOptika (plenoptika.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▼ 54.8% vs previous month
Top companies in Ophthalmology
3 companies that operate in the same segment as PlenOptika (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Plenoptika
Complete news archive for PlenOptika
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PlenOptika
PlenOptika was founded in 2014 and raised its 1st funding round 1 year after it was founded.
PlenOptika is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Shivang Dave is the CEO of PlenOptika, as recorded in our data. They have also founded this company.
PlenOptika is a funded company, having raised a total of $50.38K across 3 funding rounds to date. The company's 1st funding round was a Grant of $2.65M, raised on Sep 2015.
PlenOptika is a developer of medical devices for measuring refractive errors. The objective of the device is based on dynamic aberrometry and smart Rx algorithms. It helps to precisely determine low-order refractive errors. The device is binocular with an open view to help reduce instrument induced myopia.
PlenOptika's top competitors include EyeNetra, Smart Vision Labs and ArcScan.
PlenOptika offers QuickSee Free and QuickSee Free Pro.
PlenOptika has 1 investor. Key investors include HHS.